Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
US8133904B2 · kind B2 · utility
26Cited by
8References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 2008 |
| Grant date | Mar 13, 2012 |
| Priority date | — |
| Expiry date | Jan 17, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel pyrazoles that are useful as cannabinoid receptor antagonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, and/or cardiometabolic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.